3 days popular7 days popular1 month popular3 months popular

Robotic-Assisted Radical Bladder Surgery Potentially Benefits Bladder Cancer Patients

About 30 percent of the more than 70,000 bladder cancer cases expected in 2012 are muscle invasive. In such cases, radical cystectomy is the preferred treatment. In a pilot trial, a team of investigators assessed the efficacy of open radical cystectomy (ORC) vs. robotic-assisted laparoscopic radical cystectomy (RARC). While there were no significant differences in [...]

Bladder Cancer Drug Instiladrin™ Enters Phase II Trial After Being Cleared By FDA And RAC

FKD Therapies Oy (‘FKD’ or the ‘Company’) has announced that it has received clearance from the United States (US) Food and Drug Administration (FDA) and the US Recombinant Advisory Committee (RAC) allowing it to commence a Phase II trial for Instiladrin™ in the US. Instiladrin™ (adenovirally mediated interferon alfa 2b/Syn3) is FKD’s breakthrough gene based [...]